Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …

Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

Hepatocellular carcinoma has a substantial global mortality burden which is rising despite
advancements in tackling the traditional viral risk factors. Metabolic (dysfunction) associated …

The hepatitis C virus (HCV), a single-stranded RNA virus belonging to the Flaviviridae
family, is a major cause of hepatocellular carcinoma (HCC) worldwide. Tumors caused by …

The liver is not oblivious to the passage of time, as ageing is a major risk factor for the
development of acute and chronic liver diseases. Ageing produces alterations in all hepatic …

More than 50,000 people are diagnosed with hepatocellular carcinoma (HCC) every year in
Europe. Many cases are known to specialist liver centres years before they present with …

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is the third
most common cause of cancer-related death worldwide and a leading cause of death in …

Background & Aims The coronavirus disease–2019 pandemic profoundly disrupted
preventative health care services including cancer screening. As the largest provider of …

Background: Conflicting data regarding the incidence of hepatocellular carcinoma (HCC)
after cure of HCV infection with direct-acting antivirals (DAAs) remains. We investigated the …